TCL Archive NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement June 26, 1987
TCL Archive NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer August 26, 2005